retinal edema
Information
- Disease name
- retinal edema
- Disease ID
- DOID:6929
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
NCT ID | Status | Phase | Summary | Start date | Completion date |
---|---|---|---|---|---|
NCT01273727 | Completed | Phase 2/Phase 3 | Ozurdex for Macular Edema Post Membrane Peeling | June 2010 | April 2014 |
NCT01847638 | Completed | N/A | Prolensa (Bromfenac) 0.07% QD vs. Ilevro (Nepafenac) 0.3% QD for Treatment of Ocular Inflammation Post Cataract Surgery | April 1, 2013 | August 23, 2018 |
NCT04690608 | Not yet recruiting | Early Phase 1 | Suprachoroidal Injection of Triamcinolone Acetonide in Resistant Diabetic Macular Edema, CRVO, Pseudophakic Cystoid Macular Edema and Diabetic Macular Edema Following Pars Plana Vitrectomy | December 1, 2024 | February 1, 2025 |
NCT04501367 | Recruiting | Phase 4 | Assessing the Efficacy and Safety fo DEXTENZA, Sustained Release Dexamethasone 0.4 mg Insert(s) for the Treatment of Pain, Inflammation, and Cystoid Macular Edema Following 27 Gauge Vitrectomy With Internal Limiting Membrane Peel for the Treatment of Retinal Edema Associated With Macular Pucker. | April 27, 2021 | December 31, 2024 |
NCT05130385 | Recruiting | High Resolution Optical Coherence Tomography | November 30, 2021 | November 30, 2023 |
- Disase is a (Disease Ontology)
- DOID:5679
- Cross Reference ID (Disease Ontology)
- ICD10CM:H35.81
- Cross Reference ID (Disease Ontology)
- ICD9CM:362.83
- Cross Reference ID (Disease Ontology)
- MESH:D010211
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:6141006
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0242420